A Study of Nivolumab With Nab-Paclitaxel Plus Gemcitabine in Pancreatic Cancer

daNIS-2: NIS793 with nab-paclitaxel and gemcitabine in mPDACПодробнее

GAP study: nab-paclitaxel & gemcitabine in locally advanced, unresectable pancreatic cancerПодробнее

Dr. Ramesh Ramanathan on Nab-Paclitaxel Plus Gemcitabine in Pancreatic CancerПодробнее

Dr. Shahda on BBI-608 With Gemcitabine and Nab-Paclitaxel in Patients with mPDACПодробнее

Nab-Paclitaxel Plus Gemcitabine in Advanced Pancreatic CancerПодробнее